Abstract
Pharmacodynamics and tolerability of DT-TX 30 SE, a novel combined TXA 2/PGH 2 receptor blocker and thromboxane synthetase inhibitor, in healthy volunteers
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
